Clinical Trials Directory

Trials / Completed

CompletedNCT02873494

PHYSIOFLOW/Comparison of Cardiac Output Measurement

Impedance Cardiography by PhysioFlow® for Non-invasive Cardiac Output Monitoring: a Comparison With Trans-thoracic Echocardiography in Pediatric Intensive Care Patients.

Status
Completed
Phase
Study type
Observational
Enrollment
43 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
28 Days – 10 Years
Healthy volunteers
Not accepted

Summary

PhysioFlow® (PF®) is a new cardiac output (CO) monitoring method by impedance cardiography (IC), never studied in pediatric intensive care unit (PICU). The aim of the study was to compare CO and cardiac index (CI) measurements (IC) by trans-thoracic Doppler echocardiography (TTE) (COTTE and CITTE) and PF® (COIC and CIIC) in PICU.

Detailed description

In this monocentric prospective study in PICU of the CHRU of Lille, simultaneous sets of three measurements were realized by TTE and PF® in 43 patients. In the study, the patient will receive a measure of CF by impedancemetry chest. This electrode will be glued on the torso and the neck of the child. We will collect information obtained through IT, to compare the results obtained by the ETT, carried out under the support of the child. The study will last 15 minutes maximum. No blood sampling will be conducted for the purpose of the study, apart from the exams necessary to its support and its treatment. At no time, the results of the impedance will affect support. The study will use only the data contained in the medical file of the child and would involve no additional intervention (no examination, no further treatment). The use of these data will then be anonymous. After anonymization, information recorded will computer processing of the data collected. Concordance correlation coefficient (CCC) and Bland-Altman analysis with log-transformed data were used to compare CO, CI, stroke volume (SV) and systemic vascular resistance (SVR) measurements.

Conditions

Interventions

TypeNameDescription
DEVICEPHYSIOFLOW - PF05 Lab1TM

Timeline

Start date
2013-02-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2016-08-19
Last updated
2016-08-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02873494. Inclusion in this directory is not an endorsement.